Table 3.
ND | ND + L | HCD | HCD + L | |
---|---|---|---|---|
Serum (mg/dl) | ||||
TG | 148 ± 11a | 117 ± 9ab | 65 ± 5b | 57 ± 7b |
Total cholesterol | 50 ± 8a | 61 ± 8a | 122 ± 11b | 126 ± 6b |
Liver (mg/g) | ||||
TG | 62 ± 20 | 49 ± 8 | 46 ± 7 | 36 ± 2 |
Total cholesterol | 5.4 ± 0.4a | 4.6 ± 0.1a | 64.2 ± 1.6b | 53.6 ± 2.2c |
Hepatic injury | ||||
AST (IU) | 102 ± 16 | 145 ± 41 | 308 ± 86 | 177 ± 37 |
ALT (IU) | 44 ± 9 | 43 ± 6 | 76 ± 10 | 60 ± 7 |
Two‐way ANOVA | ||||||
---|---|---|---|---|---|---|
Serum TG | Serum T‐chol | Liver TG | Liver T‐chol | AST | ALT | |
Cholesterol | p < .001 | p < .001 | NS | p < .001 | NS | p < .01 |
LP06CC2 | p < .05 | NS | NS | p < .001 | NS | NS |
Interaction | NS | NS | NS | p < .01 | p < .055 | NS |
Data are means ± SE for six samples. Post hoc test was performed after two‐way‐ANOVA. When significant interaction was detected Tukey‐Kramer test was done to evaluate the significant different among dietary groups. NS; not significant (p > .1). Values not sharing any common superscript letter are significantly different each other.